SCHEMBL6134153

SCHEMBL6134153

Cc1ccc(S(=O)(=O)NC(=O)Nc2nc(-c3ccccc3)c(-c3ccc(=O)n(C(C)C)n3)s2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TASP1 Q9H6P5 1/20 0.46
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
LMNA P02545 1/20 0.43
FBP1 P09467 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
XIAP P98170 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
RORC P51449 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
KDM4E B2RXH2 1/20 0.40
NLRP3 Q96P20 1/20 0.40
GAA P10253 2/20 0.39
MAPT P10636 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
HPGD P15428 2/20 0.39
ADORA2A P29274 2/20 0.39
ADORA1 P30542 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6133654 0.82 ALDH1A1 (0.54) KMT2AMEN1LMNAXIAPKDM4E
SCHEMBL6133768 0.81 KCNJ6 (0.46) LMNAXIAPSMN1; SMN2KDM4EGAA
SCHEMBL6135469 0.81 XIAP (0.55) KMT2AMEN1LMNAXIAPSMN1; SMN2
SCHEMBL6133303 0.80 ADORA2A (0.60) KMT2AMEN1XIAPSMN1; SMN2ADORA3
SCHEMBL6133228 0.80 XIAP (0.48) KMT2AMEN1XIAPADORA3MAPT
SCHEMBL6133615 0.80 XIAP (0.46) XIAPADORA3MAPTALDH1A1HTT
SCHEMBL6134205 0.79 XIAP (0.43) KMT2AMEN1XIAPKDM4EMAPT
SCHEMBL6133869 0.79 CFTR (0.48) KMT2AMEN1LMNAXIAPSMN1; SMN2
SCHEMBL6134312 0.79 ALDH1A1 (0.47) XIAPSMN1; SMN2ADORA3KDM4EMAPT
Bromide SCHEMBL6134102 0.79 XIAP (0.42) KMT2AMEN1XIAPKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR TASP1 2192/4885KMT2A 2724/4885MEN1 2508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.